Through strategic guidance, visionary thinking, and a relentless pursuit of excellence, our senior executives steer SPT Labtech towards achieving its mission of making a real difference to human health through solving advanced laboratory challenges.
Learn more
Board of Directors
Our Board of Directors are committed to driving the long-term success and sustainability of SPT Labtech, providing expert guidance and oversight to execute the company’s ambitious commercial strategy.
Learn more
10
SPT Labtech and 10x Genomics Partner to Automate Single Cell Workflows
Continue reading
SPT Labtech and Agilent Introduce Automated Target Enrichment Protocols for Genomic Workflows
Continue reading
How Novartis Is Shaping the Future of Lab Automation Through Smart Sample Transport
Continue reading
Streamline and accelerate
NGS-driven Laboratory Developed Tests.
Laboratory Developed Tests (LDTs) are an integral tool in modern healthcare. They fulfill critical needs diagnosing rare diseases, providing an emergency response to global crises such as pandemics, and facilitating personalized medicine to improve patient outcomes using Next-Generation Sequencing (NGS).
firefly®, our revolutionary platform for genomics, is shaping the future of NGS-driven LDTs by combining multiple technologies for pipetting, mixing, incubating and shaking within a single compact solution. By automating repetitive and menial liquid handling tasks, you can create more efficient and streamlined workflows, reducing turnaround times and getting results to patients faster.
Designed with LDTs in mind, firefly enables you to work confidently at high-throughput levels, by delivering:
Want to learn more about how firefly can accelerate and streamline LDT workflows? Make sure to register your interest so that you don't miss out on the latest relevant news and updates from us!